DEUTERIERTES ETRAVIRIN

Patent europeic · EP2212298 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP2212298
Numer da la dumonda
EP08839230
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
17-10-2008
Publitgà
04-08-2010
Concedì
27-03-2013
Stritgà
31-10-2015
Motiv
Taxa annuala betg pajada
Classas IPC
C07D 239/48 (2006.01)
A61K 31/505 (2006.01)
A61P 31/18 (2006.01)
Prioritad
US 980869 P 18.10.2007
Dumonda PCT
PCT/US2008/011856 17.10.2008
Publicaziun PCT
WO2009/051782 23.04.2009
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 18-05-2016

    Stritgà, taxa betg pajada

    Published in Swissreg on 18.05.2016

  2. 14-01-2014

    Represchentant inscrit

    Representative
    Marks & Clerk (Luxembourg) LLP, Dreikönigstrasse 31a, 8002 Zürich

    Published in Swissreg on 14.01.2014

  3. 27-03-2013

    Concedì

    Published in Swissreg on 27.03.2013

Partidas

Possessur

Concert Pharmaceuticals, Inc.

Concert Pharmaceuticals Inc.

99 Hayden Avenue, Suite 100, Lexington, MA 02421-7966, US

Represchentant

Marks & Clerk (Luxembourg) LLP

Dreikönigstrasse 31a, 8002 Zürich

Inventur

MASSE, Craig E.

Cambridge Massachusetts 02139, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.